The authors are from the David Geffen School of Medicine, University of California, Los Angeles. Dr. Cummings is a fellow, Department of Hematology-Oncology; Dr. Kaprealian is an assistant professor, Department of Radiation Oncology; Dr. Sarantopoulos is an assistant professor, Department of Anatomic Pathology; Ms. Mendenhall is a nurse practitioner, Department of Hematology-Oncology; and Dr. Goldman is the director of Clinical Trials in Thoracic Oncology and an assistant professor, Department of Hematology-Oncology.
Dr. Kennedy is physician-in-chief, Radiation Oncology, Sarah Cannon, Nashville, TN. Dr. Garwood is physician leader, Pulmonology, Sarah Cannon. Dr. Grow is physician leader, Radiation Oncology, Sarah Cannon; and North Florida Radiation Oncology, Gainesville, FL. Mr. Lipscomb is medical physics leader, Sarah Cannon.
Disclosure: Dr. Garwood is a consultant to Medtronic, Minneapolis, MN. The remaining authors have no conflicts of interest to disclose. None of the authors received outside funding for the production of this original manuscript and no part of this article has been previously published elsewhere.
Dr. Jia is a PG-4 resident and Dr. Deek is a PG-5 resident, both in the Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD. Dr. Phillips is a senior associate consultant in the Department of Radiation Oncology, Mayo Clinic, Rochester, MN.
Disclosure: Dr. Phillips is a consultant for Reflexion Medical, Inc. The remaining authors have no conflicts of interest to disclose. None of the authors received outside funding for the production of this original manuscript and no part of this article has been previously published elsewhere.
Dr. Laucis is a resident physician in the Department of Radiation Oncology, University of Michigan, Ann Arbor.
Dr. Torgeson is a radiation oncologist at Walter Reed National Military Medical Center, Bethesda, MD. Dr. Lloyd is an associate professor, and Dr. Hitchock is a professor, both at University of Utah Department of Radiation Oncology, Salt Lake City, UT. Dr. McComas is an intern at Sacred Heart Medical Center, Spokane, WA. Mr. Stoddard is co-director, University of Utah Study Design and Biostatistics Center. Mr. Gygi is the data manager, Department of Oncology, and Dr. Avizonis is the chairperson, Department of Radiation Oncology, Intermountain Medical Center, Murray, UT. Disclosure: The authors have no conflicts of interest to disclose. None of the authors received outside funding for the production of this original manuscript and no part of this article has been previously published elsewhere. This study was highlighted as a Research Feature Presentation at the Multidisciplinary Head and Neck Cancers Symposium, Scottsdale, AZ, February 27-29, 2020.